K. S. Sakariassen

Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. A parallelism between in vivo and ex vivo thrombosis models.

V. Turitto, H. Baumgartner, K. Sakariassen, 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

Role of ADP and thromboxanes in human thrombus formation in ex vivo models.

K. Sakariassen, H. Stormorken, L. Orning, 1997, Platelets.

Methods and models to evaluate shear-dependent and surface reactivity-dependent antithrombotic efficacy.

K S Sakariassen, S. Hanson, K. Sakariassen, 2001, Thrombosis research.

Hemostatic risk factors in arterial thrombosis and atherosclerosis: the thrombin-fibrin and platelet-vWF axis.

K. Sakariassen, H. Stormorken, Helge Stormorken, 1997, Thrombosis research.

Blood flow and antithrombotic drug effects.

S. Hanson, K. Sakariassen, Kjell S. Sakariassen, 1998, American heart journal.

The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV‐077 is a more potent inhibitor of platelet function than aspirin

A. S. Sorensen, J.‐P. Meyer, H. Bounameaux, 2011, Journal of thrombosis and haemostasis : JTH.

Shear-induced platelet activation and platelet microparticle formation in native human blood.

P. Holme, N. O. Solum, F. Brosstad, 1998, Thrombosis research.

Effect of selective factor Xa inhibition on arterial thrombus formation triggered by tissue factor/factor VIIa or collagen in an ex vivo model of shear-dependent human thrombogenesis.

K. Sakariassen, U. Orvim, R. M. Barstad, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Modulation of thrombotic responses in moderately stenosed arteries by cigarette smoking and aspirin ingestion.

P. Kierulf, K. Sakariassen, U. Orvim, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.